ArticleThe pharmacogenomics journal2021

The association between missense polymorphisms in SRD5A2 and HSD3B1 and treatment failure with abiraterone for castration-resistant prostate cancer.

Masaki Shiota et al.PubMed ↗Publisher ↗

No numbers read from the abstract.